Читать книгу Intracranial Gliomas Part II - Adjuvant Therapy - Группа авторов - Страница 8

During more than 20 years I have had the opportunity to collaborate with Karger Publishers on a series of volumes related to advances in neurosurgery. Each book has had one or more editors who collaborate to produce high quality and topical reports on disorders of the nervous system and methods to diagnose and treat them. I am especially indebted to Mr. Thomas Nold and Mr. Freddy Brian who have been partners in these publications.

Dr. Mikhail Chernov first posed a volume on intracranial gliomas three years ago, and assembled a distinguished panel of colleagues—Drs. Yoshihiro Muragaki, Santosh Kesari, and Ian McCutcheon—to oversee the creation of this three-part analysis of intracranial gliomas. Part I describes current surgical concepts. Part II defines the need for and the current types of adjuvant options that are often required after surgical treatment. Part III reports both current and potential future advances that will improve the outcomes of patients with these difficult tumors. They are difficult because of their often invasive and recurrent nature, their varied molecular characteristics, their anatomic site of origin, and their need for multimodality management in many patients.

This project grew to a much bigger venture than either the editors, the authors, the series editor, or the publisher imagined. Dr. Chernov and colleagues pursued the brightest and best minds from many outstanding medical centers across the world. The culmination of this effort led to the need to produce three volumes, together totaling 690 pages. These books are beautifully edited and illustrated. The editors and authors are to be congratulated.

Part II – Adjuvant Therapy provides an up to date comprehensive review of the pathology and continually emerging knowledge base about the genetics of gliomas, followed by specific therapies that are necessary in many glioma patients. This includes current concepts of radiation therapy, radiosurgery, and chemotherapeutic options.

It concludes with reports on the challenges that brain gliomas present, and the role of rehabilitation, palliation, and supportive care of patients.

L. Dade Lunsford, MD, FACS, FAANS, Pittsburgh, PA